Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data
Published Online: 2016-02-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Bertrand Tombal•Christopher J Sweeney•Claire L Vale•David Fisher•Gwenaelle Gravis•Jayne F Tierney•Karim Fizazi•Larysa H M Rydzewska•Laurence Albiges•Mahesh K B Parmar•Malcolm D Mason•Matthew R Sydes•Nicholas D James•Noel W Clarke•Sarah Burdett
